The role of cardiopulmonary exercise tests in pulmonary arterial hypertension

“Right and Left Heart Failure Study Group” of the Italian Society of Cardiology

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Despite recent advances in the therapeutic management of patients affected by pulmonary arterial hypertension (PAH), survival remains poor. Prompt identification of the disease, especially in subjects at increased risk of developing PAH, and prognostic stratification of patients are a necessary target of clinical practice but remain challenging. Cardiopulmonary exercise test (CPET) parameters, particularly peak oxygen uptake, end-tidal carbon dioxide tension and the minute ventilation/carbon dioxide production relationship, emerged as new prognostic tools for PAH patients. Moreover, CPET provides a comprehensive pathophysiological evaluation of patients’ exercise limitation and dyspnoea, which are the main and early symptoms of the disease. This review focuses on the role of CPET in the management of PAH patients, reporting guideline recommendations for CPET and discussing the pathophysiology of exercise limitation and the most recent use of CPET in the diagnosis, prognosis and therapeutic targeting of PAH.

Original languageEnglish
Article number170134
JournalEuropean Respiratory Review
Volume27
Issue number148
DOIs
Publication statusPublished - Jun 30 2018

Fingerprint

Exercise Test
Pulmonary Hypertension
Carbon Dioxide
Exercise
Dyspnea
Ventilation
Guidelines
Oxygen
Survival
Therapeutics

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

“Right and Left Heart Failure Study Group” of the Italian Society of Cardiology (2018). The role of cardiopulmonary exercise tests in pulmonary arterial hypertension. European Respiratory Review, 27(148), [170134]. https://doi.org/10.1183/16000617.0134-2017

The role of cardiopulmonary exercise tests in pulmonary arterial hypertension. / “Right and Left Heart Failure Study Group” of the Italian Society of Cardiology.

In: European Respiratory Review, Vol. 27, No. 148, 170134, 30.06.2018.

Research output: Contribution to journalReview article

“Right and Left Heart Failure Study Group” of the Italian Society of Cardiology 2018, 'The role of cardiopulmonary exercise tests in pulmonary arterial hypertension', European Respiratory Review, vol. 27, no. 148, 170134. https://doi.org/10.1183/16000617.0134-2017
“Right and Left Heart Failure Study Group” of the Italian Society of Cardiology. The role of cardiopulmonary exercise tests in pulmonary arterial hypertension. European Respiratory Review. 2018 Jun 30;27(148). 170134. https://doi.org/10.1183/16000617.0134-2017
“Right and Left Heart Failure Study Group” of the Italian Society of Cardiology. / The role of cardiopulmonary exercise tests in pulmonary arterial hypertension. In: European Respiratory Review. 2018 ; Vol. 27, No. 148.
@article{40aa6333c7b747419a2e6847db28dca3,
title = "The role of cardiopulmonary exercise tests in pulmonary arterial hypertension",
abstract = "Despite recent advances in the therapeutic management of patients affected by pulmonary arterial hypertension (PAH), survival remains poor. Prompt identification of the disease, especially in subjects at increased risk of developing PAH, and prognostic stratification of patients are a necessary target of clinical practice but remain challenging. Cardiopulmonary exercise test (CPET) parameters, particularly peak oxygen uptake, end-tidal carbon dioxide tension and the minute ventilation/carbon dioxide production relationship, emerged as new prognostic tools for PAH patients. Moreover, CPET provides a comprehensive pathophysiological evaluation of patients’ exercise limitation and dyspnoea, which are the main and early symptoms of the disease. This review focuses on the role of CPET in the management of PAH patients, reporting guideline recommendations for CPET and discussing the pathophysiology of exercise limitation and the most recent use of CPET in the diagnosis, prognosis and therapeutic targeting of PAH.",
author = "{“Right and Left Heart Failure Study Group” of the Italian Society of Cardiology} and Stefania Farina and Michele Correale and Noemi Bruno and Stefania Paolillo and Elisabetta Salvioni and Roberto Badagliacca and Piergiuseppe Agostoni",
year = "2018",
month = "6",
day = "30",
doi = "10.1183/16000617.0134-2017",
language = "English",
volume = "27",
journal = "European Respiratory Review",
issn = "0905-9180",
publisher = "European Respiratory Society",
number = "148",

}

TY - JOUR

T1 - The role of cardiopulmonary exercise tests in pulmonary arterial hypertension

AU - “Right and Left Heart Failure Study Group” of the Italian Society of Cardiology

AU - Farina, Stefania

AU - Correale, Michele

AU - Bruno, Noemi

AU - Paolillo, Stefania

AU - Salvioni, Elisabetta

AU - Badagliacca, Roberto

AU - Agostoni, Piergiuseppe

PY - 2018/6/30

Y1 - 2018/6/30

N2 - Despite recent advances in the therapeutic management of patients affected by pulmonary arterial hypertension (PAH), survival remains poor. Prompt identification of the disease, especially in subjects at increased risk of developing PAH, and prognostic stratification of patients are a necessary target of clinical practice but remain challenging. Cardiopulmonary exercise test (CPET) parameters, particularly peak oxygen uptake, end-tidal carbon dioxide tension and the minute ventilation/carbon dioxide production relationship, emerged as new prognostic tools for PAH patients. Moreover, CPET provides a comprehensive pathophysiological evaluation of patients’ exercise limitation and dyspnoea, which are the main and early symptoms of the disease. This review focuses on the role of CPET in the management of PAH patients, reporting guideline recommendations for CPET and discussing the pathophysiology of exercise limitation and the most recent use of CPET in the diagnosis, prognosis and therapeutic targeting of PAH.

AB - Despite recent advances in the therapeutic management of patients affected by pulmonary arterial hypertension (PAH), survival remains poor. Prompt identification of the disease, especially in subjects at increased risk of developing PAH, and prognostic stratification of patients are a necessary target of clinical practice but remain challenging. Cardiopulmonary exercise test (CPET) parameters, particularly peak oxygen uptake, end-tidal carbon dioxide tension and the minute ventilation/carbon dioxide production relationship, emerged as new prognostic tools for PAH patients. Moreover, CPET provides a comprehensive pathophysiological evaluation of patients’ exercise limitation and dyspnoea, which are the main and early symptoms of the disease. This review focuses on the role of CPET in the management of PAH patients, reporting guideline recommendations for CPET and discussing the pathophysiology of exercise limitation and the most recent use of CPET in the diagnosis, prognosis and therapeutic targeting of PAH.

UR - http://www.scopus.com/inward/record.url?scp=85046626624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046626624&partnerID=8YFLogxK

U2 - 10.1183/16000617.0134-2017

DO - 10.1183/16000617.0134-2017

M3 - Review article

VL - 27

JO - European Respiratory Review

JF - European Respiratory Review

SN - 0905-9180

IS - 148

M1 - 170134

ER -